4//SEC Filing
Walts Alan Edmund 4
Accession 0001415889-21-005694
CIK 0001035354other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:16 PM ET
Size
7.4 KB
Accession
0001415889-21-005694
Insider Transaction Report
Form 4
Walts Alan Edmund
Director
Transactions
- Exercise/Conversion
Common Stock
2021-12-01+37,695→ 37,695 total - Exercise/Conversion
Restricted Stock Units
2021-12-01−37,695→ 0 total→ Common Stock (37,695 underlying)
Footnotes (3)
- [F1]The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001853544
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:16 PM ET
- Size
- 7.4 KB